Boron tribromide → HCID 10193700, compound
Reaction equation
[NH:1]1[C:9]2[C:4](=[CH:5][C:6]([NH:10][C:11]3[C:12]4[C:27]([CH3:28])=[CH:26][O:25][C:13]=4[N:14]=[C:15]([C:17]4[CH:22]=[CH:21][CH:20]=[C:19]([O:23]C)[CH:18]=4)[N:16]=3)=[CH:7][CH:8]=2)[CH:3]=[N:2]1.B(Br)(Br)Br>C(Cl)Cl>[NH:1]1[C:9]2[C:4](=[CH:5][C:6]([NH:10][C:11]3[C:12]4[C:27]([CH3:28])=[CH:26][O:25][C:13]=4[N:14]=[C:15]([C:17]4[CH:18]=[C:19]([OH:23])[CH:20]=[CH:21][CH:22]=4)[N:16]=3)=[CH:7][CH:8]=2)[CH:3]=[N:2]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of N-(1H-indazol-5-yl)-2-(3-methoxyphenyl)-5-methylfuro[2,3-d]pyrimidin-4-amine (50.0 mg, 0.13 mmol) in CH2Cl2 (20 ml) cooled to −78° C. was added BBr3 (0.7 mL, 2.83 mmol, 1M solution in CH2Cl2) drop-wise. The mixture warmed to rt and was stirred overnight. The reaction was quenched with water and the organic and aqueous phases were separated. The organic layer was dried and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (gradient from 20% to 80% EtOAc/hexane) to afford are product (8.4 mg, 17.5%). HPLC/MS: (M+H)+ 358.1 m/z. Retention time (LC-MS)=3.01 min. 1H NMR (DMSO-D6): 8.54(s, NH); 8.11 (d, 1H); 8.07(s, 1H); 7.75(m, 3H); 7.60(d, 1H); 7.47(d, 1H); 7.20(t, 1H); 6.83(m, 1H).
Workup
- customThe reaction was quenched with water
- customthe organic and aqueous phases were separated
- customThe organic layer was dried
- concentrationconcentrated under reduced pressure
- customThe crude product was purified by silica gel column chromatography (gradient from 20% to 80% EtOAc/hexane)
- customto afford
Sources & evidence
- ORD record
- ord-3885ce6ff5b1457bb21f5827f480e205
- Source dataset
- uspto-grants-2010_01
- Patent number
- US07648986B2
Reaction notes
Loading…